HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anti-tumor necrosis factor therapy does not diminish the immune response to influenza vaccine in Japanese patients with rheumatoid arthritis.

AuthorsTetsuo Kubota, Tokiko Nii, Toshihiro Nanki, Hitoshi Kohsaka, Masayoshi Harigai, Yukiko Komano, Takahiko Sugihara, Yoshinori Nonomura, Wataru Hirose, Kenji Nagasaka, Tetsushi Sakurai, Nobuyuki Miyasaka
JournalModern rheumatology (Mod Rheumatol) Vol. 17 Issue 6 Pg. 531-3 ( 2007) ISSN: 1439-7595 [Print] England
PMID18084712 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Immunoglobulin G
  • Influenza Vaccines
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Etanercept
Topics
  • Antibodies, Monoclonal (therapeutic use)
  • Antibody Formation (immunology)
  • Antirheumatic Agents (immunology, therapeutic use)
  • Arthritis, Rheumatoid (drug therapy, immunology)
  • Etanercept
  • Humans
  • Immunocompetence (drug effects, immunology)
  • Immunoglobulin G (therapeutic use)
  • Infliximab
  • Influenza Vaccines (immunology)
  • Receptors, Tumor Necrosis Factor (therapeutic use)
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: